Open Orphan #ORPH – Upcoming Investor Events

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models is delighted to be attending and presenting at a series of investor events from the 9th to 11th July 2020. Cathal Friel, Open Orphan’s Chief Executive Officer, will […]